Medications for Crohn Disease

20 results

  • abrilada - adalimumab - afzb

    (Adalimumab-Afzb)
    Pfizer Laboratories Div Pfizer Inc
    Abrilada is a TNF blocker indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis (age 2+), Crohn's disease (age 6+), ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • amjevita - adalimumab - atto injection

    (Adalimumab-Atto)
    Amgen, Inc
    TNF blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and eligible pediatric patients.
    Medication Details
    Drug Interactions

  • avsola - infliximab - axxq injection, powder, lyophilized, for solution

    (Infliximab-Axxq)
    Amgen, Inc
    Avsola is a TNF blocker for moderately to severely active Crohn's disease and ulcerative colitis (adults and children ≥6 years), rheumatoid arthritis (with methotrexate), ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis in adults.
    Medication Details
    Drug Interactions

  • cimzia - certolizumab pegol

    (Certolizumab Pegol)
    Ucb, Inc.
    CIMZIA is a TNF blocker that treats moderately to severely active Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and plaque psoriasis in adults, and polyarticular juvenile idiopathic arthritis in patients 2 years and older.
    Medication Details
    Drug Interactions

  • cyltezo - adalimumab - adbm

    (Adalimumab-Adbm)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Cyltezo is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, non-infectious uveitis in adults, and juvenile idiopathic arthritis and uveitis in pediatric patients.
    Medication Details
    Drug Interactions

  • entyvio - vedolizumab injection, powder, lyophilized, for solution

    (Vedolizumab)
    Takeda Pharmaceuticals America, Inc.
    Entyvio treats moderately to severely active ulcerative colitis and Crohn's disease in adults.
    Medication Details
    Drug Interactions

  • hadlima - adalimumab - bwwd solution

    (Adalimumab-Bwwd)
    Organon Llc
    HADLIMA is a TNF blocker for adults and children with moderately to severely active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis. Also indicated for juvenile idiopathic arthritis in patients 2 years and older.
    Medication Details
    Drug Interactions

  • hulio - adalimumab - fkjp

    (Adalimumab-Fkjp)
    Biocon Biologics Inc
    Hulio (adalimumab) is a TNF blocker indicated for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults; JIA and Crohn's disease also cover pediatric patients.
    Medication Details
    Drug Interactions

  • humira - adalimumab

    (Adalimumab)
    Abbvie Inc.
    HUMIRA is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, juvenile idiopathic arthritis, and non-infectious uveitis in adults and eligible pediatric patients.
    Medication Details
    Drug Interactions

  • hyrimoz - adalimumab - adaz injection, solution

    (Adalimumab-Adaz)
    Sandoz Inc
    Hyrimoz is a TNF-blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis (age 2+), psoriatic arthritis, ankylosing spondylitis, Crohn's disease (adults/pediatric age 6+), ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa (age 12+), and non-infectious uveitis (adults/pediatric age 2+).
    Medication Details
    Drug Interactions